Jennifer Riggs-Sauthier, Ph.D. Email & Phone Number

Huntsville, AL, US

Huntsville, Alabama, US

Score Pharma is a pre-clinical stage biotech pioneering the development of more effective second-generation antibody therapeutics (AbThx) from existing products. Our patent-pending CoreX™ platform is a discovery engine that accelerates the development of best-in-class biobetter antibody therapeutics. We transform existing clinically validated products into.

San Francisco, CA, US

Nova Mentis Pharma is a company dedicated to the search for “New Beginnings” and providing high quality solutions towards unmet medical needs. Our focused strategy is to develop medicines that limit toxicities, off target side effects and improve our patients’ quality of life. Nova Mentis is pursuing these goals in a manner that is driven exclusively by.

Baltimore, MD, US

Heart Failure has been recognized to be an inflammatory disease for over 20 years. However, several attempts to use immunomodulation to prevent and treat heart failure have failed, due to toxicity or lack of efficacy. i-Cordis brings together a world class team of cardiac immunologists and drug development experts to harvest the power of immunomodulation.

Quench Life Sciences is a Chemical Development Company based in Hyderabad, India. Quench provides range of services – Early & Late Stage Development using QbD principles, Custom Synthesis & Multi-FTE’s. Quench has designed its service model with speed & real time communication at its core.1) Early & Late-Stage Development using QbD Principles Synthetic.

Take a walk on the fiery to mild side with us! We invented recipes that matched the spiciness of the pepper with the sweet of confections. While most people attempt to create potions that will light you on fire and give you bragging rights to your friends, we choose to focus on the flavor of the peppers and marrying those unique tastes with other.

Huntsville, Alabama, US

BIO Alabama is the leading advocate for the state’s bioscience and healthcare industries, such as pharmaceuticals, medical devices, hospitals, research testing, and medical labs.Alabama’s biosciences industry currently generates $7.3 billion in annual economic activity, and supports nearly 48,000 direct and indirect jobs statewide.www.bioalabama.com

Huntsville, AL, US

Foresight Biosciences, Inc. is an Associate Company of the HudsonAlpha Institute for Biotechnology, which is a leading center for genome research located in Huntsville, Alabama. Our goal is to innovate the advancement of glycobiology research and protein therapeutics. Our specific aim is to develop solutions in protein-based drug development that address.

External Advisory Committee (EAC) members are experienced industry drug hunters with career focus in assay development/screening, medicinal chemistry, computational chemistry, drug metabolism/pharmacokinetics (DMPK), in vitro pharmacology, and in vivo pharmacology. EAC will evaluate and select projects for matching Micro Grant funding based on (1).

• Providing scientific and business expertise / guidance towards product development enabling profit generation.Key Strengths & Expertise:
• Drug Discovery & Preclinical Development through IND-enabling studies
• Medicinal Chemistry: Small Molecule, Biologics, & Polymer Conjugate Drug Design, Synthesis, Characterization
• Therapeutic Areas: Oncology, Pain, Metabolic Diseases, Inflammation, Antiviral, Rare Diseases
• Critical evaluation of new concepts / Competitive Assessment / Therapeutic Area Analysis
• Strong leadership and staff development building high functioning global cross-functional teams

San Francisco, California, US

Roles:- Member of the Senior Leadership Team, Research Executive Team and Head of Chemistry- Routinely communicate to Executive Management the status of highly visible research programs- Develop Nektar platform and pipeline with novel drug development candidates- Support discovery, pre-clinical, and IND-enabling activities leading to 1-2 development.

San Francisco, California, US

• Successful leadership of the small molecule medicinal chemistry group resulting in a highly productive and efficient team of 10 scientists with $5.0 million budget.
• Build and maintain a pipeline of novel small molecule candidates across a number of therapeutic areas (Oncology, Pain, Antiviral, Antihistamine, and Infectious Disease).
• Actively contribute and encourage inter-disciplinary communication as a core team member on 9 small molecule pre-clinical and development programs.
• Successfully lead project teams of up to 12 scientists through matrix management across 3 sites to rapidly deliver critical results.
• Liase with stakeholders in other discovery departments to evaluate biological rationale / available assets regarding new targets.
• Design and construct in collaboration with IT a global SharePoint site for all of Research to enhance inter- and intra-departmental communication and promote transparency.

San Francisco, California, US

Directed activity of 10 scientists in the small molecule group which is responsible not only for all medicinal chemistry aspects of applying the Nektar PEGylation technology to drug molecules from rational design through screening but also is a major source of ideas, concepts, and new IP generation for the Company’s pharmaceutical development. Successfully.

San Francisco, California, US

Directed activity of 10 scientists in the small molecule group which is responsible not only for all medicinal chemistry aspects of applying the Nektar PEGylation technology to drug molecules from rational design through screening but also is a major source of ideas, concepts, and new IP generation for the Company’s pharmaceutical development. Successfully.

US

• Successful leadership of the Drug Discovery & Chemical Innovation Group: Synthetic Organic Research Scientists – 3 Ph.D., 3 M.S./B.S. level synthetic chemists; Analytical Research Scientists – 1 Ph.D, 2 M.S./B.S. level.
• Directed and managed medicinal / synthetic chemistry activities (derivatization of proteins, peptides, and small molecules with assessment of bioactivity through in vitro, in vivo, and oral bioavailabilty screening) on.
• Interacted and promoted scientific discussions with cell pharmacology, animal pharmacology, analytical chemistry, clinical & regulatory, chemical development & manufacturing, formulation, and computational chemistry
• Project team lead on 5 different successful cross-functional project teams; 3 of which were partnered with Top 5 Pharmaceutical Companies (GSK, Pfizer, and BMS) in the areas of diabetes, metabolic disease, and obesity.
• Facilitated team meetings, mediated issue resolution, assigned action items, drove projects to completion over aggressive timelines
• Reviewer, primary synthetic chemist and member of IND filing team for APAZATM (small molecule for IBD)

Raleigh, North Carolina, US

Research under the direction of Dr. Jonathan S. Lindsey (Glaxo Distinguished University Professor of Chemistry) included: 1) Investigation of conditions in porphyrin-forming reactions using an automated chemistry workstation and 2) Synthesis and development of novel porphyrin systems vital to the understanding of electronic communication in the design of.

A chemical company involved with the development and manufacture of functionalized biocompatible poly(ethylene glycol) for academic, pharmaceutical, and biotechnical applications. Responsibilities included: Syntheses and development of poly(ethylene glycol) derivatives, execution of GMP procedures for large scale polymer production, and organization of.

Doctor Of Philosophy (Ph.D.), Organic Chemistry

Certificate Of Business Excellence

Bachelor’S Degree, Chemistry